NCT07758452

Brief Summary

This randomized controlled trial aims to evaluate the effectiveness of Integrated Developmental, Individual-differences, Relationship-based (DIR)/Floortime™ intervention in improving functional emotional development and adaptive behavior in children with Intellectual Developmental Disorder (IDD). Participants aged 4-12 years will be randomly assigned to receive either DIR/Floortime™ in addition to standard therapy or standard therapy alone for 10 weeks. Outcomes will be assessed using the Functional Emotional Assessment Scale (FEAS) and the Vineland Adaptive Behavior Scales (VABS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 16, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2026

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

August 6, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 11, 2026

Completed
Last Updated

August 13, 2026

Status Verified

August 1, 2026

Enrollment Period

4 months

First QC Date

August 6, 2026

Last Update Submit

August 11, 2026

Conditions

Keywords

Intellectual developmental disorderFEASVABSIDDDIR/Floortime

Outcome Measures

Primary Outcomes (4)

  • Communication Skills

    Change in Communication Skills measured using the Vineland Adaptive Behavior Scales, Third Edition (VABS-3), Communication domain Growth Scale Values (GSVs). GSVs range from 10 to 197, with higher scores indicating better adaptive functioning.

    Baseline and Week 10

  • Socialization Skills

    Change in Socialization Skills measured using the Vineland Adaptive Behavior Scales, Third Edition (VABS-3), Socialization domain Growth Scale Values (GSVs). GSVs range from 10 to 197, with higher scores indicating better adaptive functioning.

    Baseline and Week 10

  • Daily Living Skills

    Change in Daily Living Skills measured using the Vineland Adaptive Behavior Scales, Third Edition (VABS-3), Daily Living Skills domain Growth Scale Values (GSVs). GSVs range from 10 to 197, with higher scores indicating better adaptive functioning.

    Baseline and Week 10

  • Functional Emotional Development

    Change in functional emotional development measured using the Functional Emotional Assessment Scale (FEAS). FEAS items are scored from 0 to 2, with higher scores indicating better functional emotional development. Symbolic, Sensory, and Examiner scores are assessed.

    Baseline and Week 10

Study Arms (2)

DIR/Floortime + Standard Therapy

EXPERIMENTAL

Participants receive Integrated DIR/Floortime™ in addition to their routine standard therapeutic services for 10 weeks.

Behavioral: DIR/Floortime™

Standard Therapy

ACTIVE COMPARATOR

Participants continue to receive routine standard therapeutic services without the addition of DIR/Floortime™ for 10 weeks.

Behavioral: Standard therapy

Interventions

Integrated Developmental, Individual-differences, Relationship-based (DIR)/Floortime™ intervention delivered for 10 weeks in addition to standard therapy

DIR/Floortime + Standard Therapy

Routine therapeutic services provided without DIR/Floortime™ during the 10-week study period.

Standard Therapy

Eligibility Criteria

Age4 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 4-12 years.
  • Clinical diagnosis of Intellectual Developmental Disorder (IDD) according to DSM-5-TR criteria.
  • Mild to moderate intellectual developmental impairment.
  • Receiving routine therapeutic services.
  • Able to participate in the 10-week DIR/Floortime™ intervention and study assessments.
  • Written informed consent obtained from a parent or legal guardian.

You may not qualify if:

  • Profound or severe Intellectual Developmental Disorder preventing meaningful participation in the intervention.
  • Severe visual, hearing, or physical impairments that would interfere with assessments or intervention.
  • Major neurological or genetic disorders that could affect study participation.
  • Serious medical or psychiatric conditions requiring intensive treatment.
  • Participation in another intervention study during the study period.
  • Parent or legal guardian unwilling to provide written informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SEND Therapy Center

Gujranwala, Punjab Province, Pakistan

Location

MeSH Terms

Conditions

Intellectual Disability

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

August 6, 2026

First Posted

August 11, 2026

Study Start

March 16, 2026

Primary Completion

July 15, 2026

Study Completion

August 1, 2026

Last Updated

August 13, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual Participant Data (IPD) will not be shared. The study involves confidential data from children with Intellectual Developmental Disorder, and participant privacy and confidentiality will be protected in accordance with institutional ethical approval and informed consent.

Locations